Advertisement
UK markets close in 2 hours 20 minutes
  • FTSE 100

    8,067.00
    +26.62 (+0.33%)
     
  • FTSE 250

    19,651.51
    -67.86 (-0.34%)
     
  • AIM

    754.15
    -0.54 (-0.07%)
     
  • GBP/EUR

    1.1668
    +0.0024 (+0.20%)
     
  • GBP/USD

    1.2473
    +0.0011 (+0.09%)
     
  • Bitcoin GBP

    50,574.00
    -2,456.24 (-4.63%)
     
  • CMC Crypto 200

    1,349.83
    -32.74 (-2.37%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.96
    +0.15 (+0.18%)
     
  • GOLD FUTURES

    2,341.90
    +3.50 (+0.15%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,900.30
    -188.40 (-1.04%)
     
  • CAC 40

    7,981.32
    -110.54 (-1.37%)
     

Investors bid Optiscan Imaging (ASX:OIL) up AU$25m despite increasing losses YoY, taking three-year CAGR to 59%

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But if you buy shares in a really great company, you can more than double your money. For instance the Optiscan Imaging Limited (ASX:OIL) share price is 300% higher than it was three years ago. Most would be happy with that. In the last week the share price is up 40%.

Since it's been a strong week for Optiscan Imaging shareholders, let's have a look at trend of the longer term fundamentals.

View our latest analysis for Optiscan Imaging

Optiscan Imaging wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually expect strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

ADVERTISEMENT

In the last 3 years Optiscan Imaging saw its revenue grow at 22% per year. That's much better than most loss-making companies. Along the way, the share price gained 59% per year, a solid pop by our standards. But it does seem like the market is paying attention to strong revenue growth. Nonetheless, we'd say Optiscan Imaging is still worth investigating - successful businesses can often keep growing for long periods.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
earnings-and-revenue-growth

We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. It might be well worthwhile taking a look at our free report on Optiscan Imaging's earnings, revenue and cash flow.

A Different Perspective

Investors in Optiscan Imaging had a tough year, with a total loss of 18%, against a market gain of about 1.2%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 7%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Optiscan Imaging has 5 warning signs (and 3 which are a bit unpleasant) we think you should know about.

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here